Skip to main content

Advertisement

Table 1 Pediatric AML patients' characteristics

From: Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia

AML Primary (N = 131) Characteristics Median (range) No. (%)
  Age at diagnosis, y 7.8 (0-14)  
  Sex   
     Male   79 (60.3)
     Female   52 (39.7)
  WBC count, ×10 9 /L 18.2 (1.1-292)  
     Less than 10   76 (58)
     10-50   34 (26)
     50 or higher   21 (16)
  FAB   
     M1   9 (6.9)
     M2   27 (20.6)
     M3   76 (58)
     M4   5 (3.8)
     M5   11 (8.4)
     M6   3 (2.3)
M3 after therapy (N = 38) #CR   33 (86.8)
  &Relapse   5 (13.2)
  1. AML: acute myelogenous leukemia; WBC: white blood cell; FAB: French-American-British classification; CR: complete remission.
  2. #: CR samples are from 33 patients of 76 M3 primary patients with three years clinical follow-up;
  3. &: with three years clinical follow-up.